TOP STORIES

• REGULATORY AstraZeneca, Moderna COVID-19 Vaccines Up for Key Panel Review on May 20
  May 17, 2021

• BUSINESS Big 4 Wholesalers’ Operating Margin Sinks to 0.49% on COVID-19, Competition
  May 17, 2021

• BUSINESS 2 Ono Employees Admits Bribery Charges over Onoact Prescriptions
  May 17, 2021

• REGULATORY Japan, Pfizer Agree on 50 Million Extra Vaccine Doses by Sept-End
  May 17, 2021

• BUSINESS FY2020 Sales of 7 Major Japan Drug Makers Slip 2.7% on COVID-19, Price Woes: Tally
  May 14, 2021

• BUSINESS Ono Cuts Opdivo Guidance to 110 Billion Yen for FY2021
  May 14, 2021

• REGULATORY Pharma Groups Want Price Maintenance for Patented Meds, Payer Sees It “Natural” to Rectify Gap: Chuikyo
  May 13, 2021

• REGULATORY Chuikyo OKs Re-Pricing for Tecentriq, Vyndaqel; 3 I/O Peers Challenge Cuts in Vain
  May 13, 2021

• REGULATORY May Listing OK’ed for Darzquro, Pemazyre, Vitrakvi, Kesimpta and More
  May 12, 2021

• REGULATORY Ultomiris Faces 4.3% Price Cut under CEA Scheme
  May 12, 2021

• REGULATORY Tecentriq, 3 I/O Rivals Face Quarterly Re-Pricing; Price Cuts Yet Again for Opdivo, Keytruda
  May 11, 2021

• BUSINESS Takeda Submits Positive Japan Data for Approval-Pending Moderna Vaccine
  May 11, 2021

• BUSINESS Novartis Says Only 3,000 Pollen Allergy Patients Used Xolair This Season, Less than 10% of Re-Pricing Line
  May 10, 2021

• ORGANIZATION JPMA Has “Different View” from US Govt on COVID-19 Vaccine IP Waiver
  May 10, 2021

• BUSINESS Kyoto Startup to Begin Clinical Trial of iPSC-Derived Platelet Agent This Year, Eyes 10 Billion Yen Biz
  May 10, 2021

• BUSINESS Drug Makers’ Female Manager Ratio at 12.5%; Major Gap between Japan, Foreign Players
  April 30, 2021

• REGULATORY MHLW Revokes Approval for 12 Kobayashi Kako Products, Imposes Biz Improvement Order
  April 30, 2021

• BUSINESS Takeda, Eisai, Chemiphar Ran Early Retirement Programs over Past Year: Survey
  April 28, 2021

• BUSINESS Boehringer’s Japan Pharma Sales Rise 3.1% in 2020 on Ofev, Jardiance
  April 28, 2021

• BUSINESS Novartis Offering Voluntary Redundancy for 3rd Consecutive Year, Targets Sales & Medical across Therapeutic Areas
  April 27, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 100
• 101
• 102
• 103
• 104
• 105
• 106
• 107
• 108
• …
• Next ›
• 最終 »